Journal

PLAB 2 is 16 scenarios of eight minutes each. Assessing AI patient platforms against that real examination structure, rather than against raw case count, across Simsbuddy, MyMedi8 ...

A multi-exam simulation platform against an integrated undergraduate curriculum ecosystem. Quesmed's small marking-calibration pilot is genuinely interesting and genuinely not vali...

Multi-exam flexibility and a human-tutor marketplace against the largest established UK OSCE ecosystem. The test protocol worth running yourself, and why the decision depends on th...

Separate expert-written case banks for the SCA, PLAB 2, PACES, CASC and UKMLA, voice-based AI patients and a human-tutor marketplace. What Simsbuddy actually offers across five ver...

OpenAI has not announced NICE or emc connectors. This is a speculative proposal for what a genuine UK Healthcare Public Data plugin would need to represent: not a translation of Am...

Anthropic had already introduced healthcare connectors covering PubMed, CMS data, ICD-10 and the NPI Registry before OpenAI's 1 September announcement. The connector race may matte...

DailyMed, RxNorm and openFDA answer three different medicines questions: what does the label say, how is the medicine identified consistently, and what public safety data exists. O...

PubMed and ClinicalTrials.gov are internationally relevant. DailyMed, RxNorm, openFDA, CMS Coverage, Medicare Care Compare and the NPI Registry are specifically rooted in American ...

DailyMed materially improves US medicines information. It does not create a UK medication reference layer. Why a correct US product label can still produce a wrong UK prescribing a...

PubMed, ClinicalTrials.gov, DailyMed, RxNorm, openFDA, CMS Coverage, CMS Open Data, Medicare Care Compare and the NPI Registry answer nine genuinely different questions. What each ...

ClinicalKey AI, Dyna AI, UpToDate Expert AI, OpenEvidence and ChatGPT for Clinicians compared by jurisdiction: a powerful global evidence tool is not automatically the right tool f...

Deprescribing is not prescribing in reverse: goals, time to benefit, withdrawal risk and what matters to the resident lead; how AI can organise a fourteen-medicine review without p...